UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transplant Eligible Maintenance

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e10-e10

2015

Volltextzugriff (PDF)

Analysis of Second Primary Malignancies (SPMs) in CALGB (Alliance)/ECOG/BMT CTN 100104

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e61-e62

2015

Volltextzugriff (PDF)

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.203-211

2012

Volltextzugriff (PDF)

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

Annals of oncology, 2017-02, Vol.28 (2), p.228-245

2017

Volltextzugriff (PDF)

Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1024-1029

2015

Volltextzugriff (PDF)

Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.416-421

2014

Volltextzugriff (PDF)

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

Bone marrow transplantation (Basingstoke), 2012-06, Vol.47 (6), p.810-816

2012

Volltextzugriff (PDF)

Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2013-06, Vol.48 (6), p.865-871

2013

Volltextzugriff (PDF)

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

Annals of oncology, 2018-04, Vol.29 (4), p.1074-1074

2018

Volltextzugriff (PDF)

Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice

Bone marrow transplantation (Basingstoke), 2009-03, Vol.43 (5), p.351-356

2009

Volltextzugriff (PDF)

Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders

Bone marrow transplantation (Basingstoke), 2015-03, Vol.50 (3), p.367-374

2015

Volltextzugriff (PDF)

Is the international staging system superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

Leukemia, 2009-08, Vol.23 (8), p.1528-1534

2009

Volltextzugriff (PDF)

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1

Bone marrow transplantation (Basingstoke), 2014-09, Vol.49 (9), p.1176-1183

2014

Volltextzugriff (PDF)

Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.248-253

2014

Volltextzugriff (PDF)

High prevalence of early-onset osteopenia osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy

Bone marrow transplantation (Basingstoke), 2008-02, Vol.41 (4), p.393-398

2008

Volltextzugriff (PDF)

Sarcoidosis-associated MHC Ags and the development of cutaneous and nodal granulomas following allogeneic hematopoietic cell transplant

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.1032-1034

2011

Volltextzugriff (PDF)

Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation

Transplant infectious disease, 2007-03, Vol.9 (1), p.28-32

2007

Volltextzugriff (PDF)

Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation

Bone marrow transplantation (Basingstoke), 2011-06, Vol.46 (6), p.876-879

2011

Volltextzugriff (PDF)

Effects of Body Mass Index (BMI) in Children Undergoing Allogeneic Bone Marrow Transplant (BMT) for Hematologic Malignancies

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S230-S230

2012

Volltextzugriff (PDF)

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

Bone marrow transplantation (Basingstoke), 2008-04, Vol.41 (7), p.635-642

2008

Volltextzugriff (PDF)

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

Bone marrow transplantation (Basingstoke), 2011-01, Vol.46 (1), p.34-43

2011

Volltextzugriff (PDF)

Transplant Utilization, Procedure Patterns And Patient Characteristics In North American Transplant Centers From 1994-2005

Biology of blood and marrow transplantation, 2010, Vol.16 (2), p.S198-S199

2010

Volltextzugriff (PDF)

Patient and Family Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation (HCT): A Pilot Study

Biology of blood and marrow transplantation, 2012, Vol.18 (2), p.S237-S238

2012

Volltextzugriff (PDF)

Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2010-08, Vol.45 (8), p.1363-1364

2010

Volltextzugriff (PDF)

318: Extracorporeal photopheresis (ECP) for the treatment of steroid-refractory or -intolerant chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplant (HSCT)

Biology of blood and marrow transplantation, 2007, Vol.13 (2), p.115-116

2007

Volltextzugriff (PDF)

1 – 25 von 97

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(95)
Berichte
(2)

Sprache

Englisch
(96)
Spanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(46)
Life Sciences & Biomedicine
(35)
Humans
(26)
Biological And Medical Sciences
(23)
Immunology
(23)
Transplantation
(23)
Oncology
(22)
Hematology
(20)
Middle Aged
(20)
Stem Cell Transplantation
(20)
Biophysics
(19)
Female
(19)
Male
(19)
Stem Cells
(19)
Hematology, Oncology And Palliative Medicine
(18)
Medical Sciences
(18)
Adult
(17)
Cell Biology
(17)
Internal Medicine
(17)
Medicine
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transplant Eligible Maintenance

Analysis of Second Primary Malignancies (SPMs) in CALGB (Alliance)/ECOG/BMT CTN 100104

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

Consolidation and maintenance therapy for multiple myeloma after autologous transplantation: where do we stand?

Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation

Second primary malignancies in multiple myeloma: an overview and IMWG consensus

Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice

Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders

Is the international staging system superior to the Durie-Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant

Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1

Acute GVHD prophylaxis with standard-dose, micro-dose or no MTX after fludarabine/melphalan conditioning

High prevalence of early-onset osteopenia osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy

Sarcoidosis-associated MHC Ags and the development of cutaneous and nodal granulomas following allogeneic hematopoietic cell transplant

Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation

Medical management of pneumatosis intestinalis in patients undergoing allogeneic blood and marrow transplantation

Effects of Body Mass Index (BMI) in Children Undergoing Allogeneic Bone Marrow Transplant (BMT) for Hematologic Malignancies

Long-term outcomes of adults with acute lymphoblastic leukemia after autologous or unrelated donor bone marrow transplantation: a comparative analysis by the National Marrow Donor Program and Center for International Blood and Marrow Transplant Research

Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia

Transplant Utilization, Procedure Patterns And Patient Characteristics In North American Transplant Centers From 1994-2005

Patient and Family Out-of-Pocket Costs of Allogeneic Hematopoietic Cell Transplantation (HCT): A Pilot Study

Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation

318: Extracorporeal photopheresis (ECP) for the treatment of steroid-refractory or -intolerant chronic graft-versus-host disease (cGVHD) following allogeneic hematopoietic stem cell transplant (HSCT)

Suchergebnisse filtern